Evidence map›Paper›PMID 39064515›Full record

ArticleMedicina (Kaunas, Lithuania)2024

Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant

Saadia Ijaz, Farheen Ansari, Muhammad Nawaz, Hasan Ejaz, Aftab Ahmad Anjum, Aqib Saeed, Tehreem Ali, Obaid Ur Rehman, Eeshal Fatima, Tayyaba Ijaz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Advancements in AI-driven drug sensitivity testing research.Frontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Saadia IjazInstitute of Molecular Biology & Biotechnology (IMBB), University of Lahore, Lahore 54590, Pakistan.
Farheen AnsariInstitute of Molecular Biology & Biotechnology (IMBB), University of Lahore, Lahore 54590, Pakistan.
Muhammad NawazInstitute of Microbiology, University of Veterinary and Animal Sciences, Lahore 54000, Pakistan.ORCID 0000-0001-6205-7350
Hasan EjazDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia.ORCID 0000-0002-6185-2042
Aftab Ahmad AnjumInstitute of Microbiology, University of Veterinary and Animal Sciences, Lahore 54000, Pakistan.ORCID 0000-0001-8262-8720
Aqib SaeedInstitute of Microbiology, University of Veterinary and Animal Sciences, Lahore 54000, Pakistan.
Tehreem AliInstitute of Microbiology, University of Veterinary and Animal Sciences, Lahore 54000, Pakistan.ORCID 0000-0003-0037-3061
Obaid Ur RehmanDepartment of Medicine, Services Institute of Medical Sciences, Lahore 54000, Pakistan.
Eeshal FatimaDepartment of Medicine, Services Institute of Medical Sciences, Lahore 54000, Pakistan.ORCID 0009-0004-7103-9364
Tayyaba IjazMayo Hospital, Health Department, Lahore 54000, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsCarbapenemsMicrobial Sensitivity TestsAcinetobacter InfectionsBacterial Proteinsbeta-LactamasesDrug Therapy, CombinationHumansPhylogenyAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsA. baumanniicarbapenem resistancecheckerboard method

Identifiers

PMID39064515
PMCPMC11278937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.